Barrington Research reaffirmed their outperform rating on shares of Stericycle Inc. (NASDAQ:SRCL) in a research note published on Wednesday morning. Barrington Research currently has a $88.00 price target on the stock, down from their previous price target of $100.00.

A number of other analysts also recently weighed in on the company. Zacks Investment Research upgraded Stericycle from a strong sell rating to a hold rating in a research report on Wednesday, September 28th. Robert W. Baird dropped their target price on Stericycle from $99.00 to $85.00 and set a neutral rating for the company in a research report on Friday, September 23rd. Wedbush dropped their target price on Stericycle from $95.00 to $85.00 and set a neutral rating for the company in a research report on Thursday, September 22nd. Northcoast Research downgraded Stericycle from a buy rating to a neutral rating in a research report on Tuesday, September 20th. Finally, RBC Capital Markets restated an underperform rating and issued a $77.00 target price (down previously from $89.00) on shares of Stericycle in a research report on Monday, September 19th. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and four have issued a buy rating to the stock. The company has an average rating of Hold and an average price target of $103.54.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Shares of Stericycle (NASDAQ:SRCL) traded up 0.05% during mid-day trading on Wednesday, hitting $76.62. 1,243,238 shares of the stock traded hands. The firm’s 50-day moving average is $82.10 and its 200-day moving average is $99.74. The stock has a market cap of $6.52 billion, a price-to-earnings ratio of 26.97 and a beta of 0.20. Stericycle has a 52 week low of $75.31 and a 52 week high of $151.57.

Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, July 28th. The company reported $1.18 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $1.18. The company earned $891.60 million during the quarter, compared to the consensus estimate of $910.29 million. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. Stericycle’s quarterly revenue was up 24.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS. On average, analysts forecast that Stericycle will post $4.67 earnings per share for the current year.

In other news, Director Rodney F. Dammeyer sold 10,188 shares of the company’s stock in a transaction on Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total transaction of $871,074.00. Following the transaction, the director now directly owns 10,188 shares of the company’s stock, valued at $871,074. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Mark C. Miller sold 34,835 shares of the company’s stock in a transaction on Friday, July 8th. The shares were sold at an average price of $104.52, for a total value of $3,640,954.20. Following the transaction, the director now directly owns 244,284 shares in the company, valued at $25,532,563.68. The disclosure for this sale can be found here. Insiders own 3.30% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in SRCL. Parkside Financial Bank & Trust increased its position in shares of Stericycle by 2.9% in the second quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the company’s stock worth $149,000 after buying an additional 41 shares during the last quarter. Genesee Valley Trust Co. increased its position in Stericycle by 1.0% in the second quarter. Genesee Valley Trust Co. now owns 4,511 shares of the company’s stock worth $470,000 after buying an additional 43 shares in the last quarter. Spero Smith Investment Advisers Inc. OH increased its position in Stericycle by 0.3% in the second quarter. Spero Smith Investment Advisers Inc. OH now owns 16,883 shares of the company’s stock worth $1,758,000 after buying an additional 50 shares in the last quarter. Ameritas Investment Partners Inc. increased its position in Stericycle by 1.7% in the second quarter. Ameritas Investment Partners Inc. now owns 3,091 shares of the company’s stock worth $322,000 after buying an additional 53 shares in the last quarter. Finally, Mn Services Vermogensbeheer B.V. increased its position in Stericycle by 2.7% in the second quarter. Mn Services Vermogensbeheer B.V. now owns 2,159 shares of the company’s stock worth $202,000 after buying an additional 57 shares in the last quarter. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

About Stericycle

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.